Trial Information

Summary: A 21 WEEK STUDY TO EVALUATE SAFETY AND EFFICACY OF ORAL FAMPRIDINE-SR IN SUBJECTS WITH MULTIPLE SCLEROSIS.

The purpose of the study is to evaluate the safety and effectiveness of a new experimental drug, Fampridine-SR. Fampridine is being studied to see if it can improve walking ability and muscle strength in persons with MS.
Compensation Provided

Patient Inclusion/Exclusion Criteria:

Male or female with clinically definite MS
Subject must be 18 to 70 years of age

Female who is either pregant or breastfeeding
History of any seizure activities
Allergic to pyridine-containing substances
Previously treated with 4-AP
Medical condition (including psychiatric disease) that would interfere with the interpretation of the study results or the conduct of the study

Contact:

Michele Weber, CCRC
Mount Sinai Medical Center
One Gustave L. Levy Place

New York, NY 10029
Telephone: 212-241-4264
Fax: 212-241-9771
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:45:02 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA